TRIKAFTA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 29 Dec 2025)
What this means for you
Registered since 17 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87924202
- Registration number
- 5938974
- Mark type
- Design + words
- Filed
- 16 May 2018
- Published for opposition
- 21 Aug 2018
- Registered
- 17 Dec 2019
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cystic fibrosis
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prior registrations
Prosecution history
- 29 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 17 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 13 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Oct 2019 — USE AMENDMENT FILED
- 09 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Oct 2019 — TEAS STATEMENT OF USE RECEIVED
- 18 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2019 — SOU EXTENSION 2 GRANTED
- 16 Oct 2019 — SOU EXTENSION 2 FILED